Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
Soda Industry Steals Page From Tobacco To Combat Taxes On Sugary Drinks
Voters in Oregon, Washington will decide whether to strip cities of ability to tax sugary drinks.
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
La “medicina de precisión” para combatir el cáncer no siempre logra su objetivo
Estas terapias focalizadas, que ajustan la medicina a la genética de la enfermedad, no tienen el éxito que los médicos, y el público en general, esperan.
Much Touted For Cancer, ‘Precision Medicine’ Often Misses The Target
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
For Nursing Home Patients, Breast Cancer Surgery May Do More Harm Than Good
A new study of 6,000 older patients shows little gain from surgeries for breast cancer.
The Man Who Sold America On Vitamin D — And Profited In The Process
The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.
Kate Spade’s Death Ignites Concern About Rising Suicide Rate
At least 45,000 Americans commit suicide every year, often tied to mental health issues or substance abuse.
Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
